Bobur Kholikov/LinkedIn
Oct 7, 2025, 13:06
Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
Bobur Kholikov, Regional Sales Manager at YHLO, shared a post on LinkedIn:
”iFlash Thrombosis Panel – D-Dimer
D-Dimer is a key biomarker of fibrin degradation, widely used to rule out or confirm thrombosis-related conditions. Elevated levels indicate active clot formation and breakdown, making it a crucial marker in emergency and routine care.
Clinical Value
- Excludes venous thromboembolism (VTE) with high negative predictive value
- Supports diagnosis of DVT, PE, and DIC
- Monitoring of anticoagulant therapy effectiveness
With the iFlash Thrombosis Panel, YHLO provides clinicians with reliable insights into coagulation and fibrinolysis, enhancing early intervention and improving patient outcomes.
Together, make a difference.”
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia